Clinical Trials Browser

pamiparib × Other solid neoplasm × 90 days × Clear all

NCT05038839 2026-05-12

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Malignant Solid Neoplasm